Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, Gai LY, Ge JB, Wang WM, Du ZM, Huo Y, Wang LF, Gao W, Chen JY, He B, Jia GL, Yang ZJ, Cao KJ, Li WM, Shen WF, Wan Z, Huang DJ, Zhu GY; CCSR Investigators. Gao RL, et al. Among authors: huo y. Int J Cardiol. 2008 Apr 25;125(3):339-46. doi: 10.1016/j.ijcard.2007.02.031. Epub 2007 Apr 16. Int J Cardiol. 2008. PMID: 17434617
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
Xu B, Dou KF, Han YL, Lü SZ, Yang YJ, Huo Y, Wang LF, Chen YD, Wang HC, Li WM, Chen JY, Wang L, Wang Y, Ge JB, Li W, Gao RL. Xu B, et al. Among authors: huo y. Chin Med J (Engl). 2011 Mar;124(6):811-6. Chin Med J (Engl). 2011. PMID: 21518585 Clinical Trial.
Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
Yuan F, Chen X, Song X, Wang D, Zhang Z, Li W, Li Z, Li H, Chen X, Huo Y, Wang L, Lu C, Lu Q, Xu B, Li W, Lyu S; HOPE Investigator. Yuan F, et al. Among authors: huo y. Chin Med J (Engl). 2014;127(14):2561-6. Chin Med J (Engl). 2014. PMID: 25043067 Clinical Trial.
[Efficacy comparison between 5 mg perindopril arginine salt and 4 mg perindopril tert-butylamine salt for patients with mild to moderate essential hypertension].
Qi L, Zhao S, Li H, Guo Y, Xu G, Ge J, Wu S, Miao P, Jin Y, Yang J, Wu X, Ma C, Xu D, Luo J, Wang B, Li G, Wang F, Shen F, Shi H, Huo Y. Qi L, et al. Among authors: huo y. Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Oct;43(10):863-7. Zhonghua Xin Xue Guan Bing Za Zhi. 2015. PMID: 26652987 Clinical Trial. Chinese.
Management of morning hypertension: a consensus statement of an Asian expert panel.
Wang JG, Kario K, Chen CH, Park JB, Hoshide S, Huo Y, Lee HY, Li Y, Mogi M, Munakata M, Park S, Zhu D. Wang JG, et al. Among authors: huo y. J Clin Hypertens (Greenwich). 2018 Jan;20(1):39-44. doi: 10.1111/jch.13140. Epub 2018 Jan 16. J Clin Hypertens (Greenwich). 2018. PMID: 29338119 Free PMC article. Review.
3,627 results